SCHEMBL10201296

SCHEMBL10201296

Cn1nc(-c2ccccc2F)cc1-c1ncc(NC(=O)c2ccccc2F)s1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STIM1 Q13586 5/20 0.71
ORAI1 Q96D31 5/20 0.71
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
RXFP1 Q9HBX9 2/20 0.48
MAPT P10636 3/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTPRC P08575 2/20 0.40
P4HTM Q9NXG6 1/20 0.40
CTSL P07711 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10262336 0.93 STIM1 (0.62) STIM1ORAI1NPC1RAB9ARXFP1
SCHEMBL10201301 0.92 STIM1 (0.61) STIM1ORAI1NPC1RAB9ARXFP1
SCHEMBL16900160 0.91 STIM1 (0.60) STIM1ORAI1NPC1RAB9ARXFP1
SCHEMBL10201293 0.90 STIM1 (0.57) STIM1ORAI1MAPTTP53
SCHEMBL16900159 0.88 STIM1 (0.55) STIM1ORAI1NPC1RAB9AMAPT
SCHEMBL10201306 0.87 STIM1 (0.54) STIM1ORAI1NPC1RAB9AMAPT
SCHEMBL10201298 0.86 STIM1 (0.56) STIM1ORAI1NPC1RAB9AMAPT
SCHEMBL10201305 0.85 STIM1 (0.53) STIM1ORAI1NPC1RAB9AKMT2A
SCHEMBL10201299 0.85 STIM1 (0.54) STIM1ORAI1MAPTPOLBTP53
SCHEMBL10201282 0.84 STIM1 (0.54) STIM1ORAI1NPC1RAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336738-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2019-07-02 US disclosed
US-20150344469-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM AVENUE CAPITAL MANAGEMENT II, L.P. 2015-12-03 US disclosed
US-20150344469-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM AVENUE CAPITAL MANAGEMENT II, L.P. 2015-12-03 US disclosed
US-9079891-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2015-07-14 US disclosed
US-9079891-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2015-07-14 US disclosed
US-20120053210-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-01 US disclosed
US-20120053210-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336738-B2 Compounds that modulate intracellular calcium ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885NPC1 262/4885
US-20150344469-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885NPC1 262/4885
US-20120053210-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885NPC1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.